Alveolar Soft Part Sarcoma of the Uterine Cervix: A Case Report and Review of the Literature
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Alveolar soft part sarcoma (ASPS) of the uterine cervix is a rare malignancy, and 21 cases have been reported the literature from every language (including our case). Herein, we describe a 17-year-old female patient who presented with active vaginal bleeding. Pelvic examination revealed a 1.6×1.0×0.5-cm-sized soft mass protruding from the uterine cervix. The final pathological diagnosis was ASPS of the uterine cervix. Immunohistochemically, tumor cells were strongly nuclear positive for transcription factor E3. The patient remained disease free for 24 months without adjuvant therapy. The prognosis of ASPS in the cervix is considerably better than that of ASPS in soft tissues due to early clinical detection, small size, and resectability. ASPS should be considered in the differential diagnosis of an unusual epithelioid neoplasm showing organoid appearance with mild cytologic atypia and no/rare mitotic figures, particularly in young women. Pathologists shouldbe aware of those unusual locations where ASPS may originate.
Abstract
Alveolar soft part sarcoma (ASPS) of the uterine cervix is a rare malignancy, and 21 cases have been reported the literature from every language (including our case). Herein, we describe a 17-year-old female patient who presented with active vaginal bleeding. Pelvic examination revealed a 1.6×1.0×0.5-cm-sized soft mass protruding from the uterine cervix. The final pathological diagnosis was ASPS of the uterine cervix. Immunohistochemically, tumor cells were strongly nuclear positive for transcription factor E3. The patient remained disease free for 24 months without adjuvant therapy. The prognosis of ASPS in the cervix is considerably better than that of ASPS in soft tissues due to early clinical detection, small size, and resectability. ASPS should be considered in the differential diagnosis of an unusual epithelioid neoplasm showing organoid appearance with mild cytologic atypia and no/rare mitotic figures, particularly in young women. Pathologists shouldbe aware of those unusual locations where ASPS may originate.
참고문헌 (13)
- Weiss SW, "Enzinger and Weiss’s soft tissue tumors", pp.1182~1191 (2008), Mosby
- Fadare O, "Uncommon sarcomas of the uterine cervix: a review of selected entities", Diagn Pathol, 1, pp.30~ (2006)
- Nielsen GP, "Alveolar soft-part sarcoma of the female genital tract: a report of nine cases and review of the literature", Int J Gynecol Pathol, 14, pp.283~292 (1995)
- Kwon GY, "Alveolar soft part sarcoma of the uterine cervix: a case report", Korean J Pathol, 30, pp.933~938 (1996)
- Zhang JK, "Alveolar soft part sarcoma of the uterine cervix: a case report", J Hebei Med Coll Cont Educ, 18, pp.4~5 (2001)
- Wang M, "Alveolar soft part sarcoma of the uterine cervix: a case report", Henan J Oncol, 15, pp.91~92 (2002)
- Mu YL, "Clinical analysis of alveolar soft-tissue sarcoma of the uterine cervix: a case report", Chin Med J, 123, pp.1612~1614 (2010)
- Hasegawa K, "A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature", Int J Clin Oncol, 16, pp.751~758 (2011)
- Kang WD, "Alveolar soft part sarcoma of the uterine cervix in a woman presenting with postmenopausal bleeding: a case report and literature review", EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 32(3), pp.359~361 (2011), I R O G CANADA
- Williams A, "Detection of ASPL", TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features, 2011, pp.458, 291~300
- Zhang LL, "Alveolar soft part sarcoma of the uterine corpus with pelvic lymph node metastasis: case report and literature review", Int J Clin Exp Pathol, 5, pp.715~719 (2012)
- Ladanyi M, "The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25", Oncogene, 20, pp.48~57 (2001)
- Argani P, "Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay", Am J Surg Pathol, 27, pp.750~761 (2003)